Caris Life Sciences (CAI) Free Cash Flow (2024 - 2026)

Caris Life Sciences' Free Cash Flow history runs 3 years deep, the most recent figure standing at $33.0 million for Q1 2026.

• In Q1 2026, Free Cash Flow rose 205.52% year-over-year to $33.0 million; the TTM figure through Mar 2026 stood at $147.5 million (up 202.62% YoY), while the FY2025 annual figure was $83.2 million, up 132.8% from the prior year.
• Free Cash Flow for Q1 2026 stood at $33.0 million, down from $56.0 million in the prior quarter.
• The five-year high for Free Cash Flow was $56.0 million in Q4 2025, with the low at -$65.3 million in Q3 2024.
• The 3-year median for Free Cash Flow is $3.2 million (2025), against an average of $538000.0.
• Peak annual rise in Free Cash Flow reached 218.62% in 2025, while the deepest fall reached 184.79% in 2025.
• Caris Life Sciences' Free Cash Flow stood at -$47.2 million in 2024, then soared by 218.62% to $56.0 million in 2025, then slumped by 41.02% to $33.0 million in 2026.
• Business Quant data shows CAI's Free Cash Flow at $33.0 million in Q1 2026, $56.0 million in Q4 2025, and $55.3 million in Q3 2025.